The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $851,811 in first-year total cost, median $252,000.
Most frequent study sections
- Special Emphasis Panel[ZRG1 CFS-N (80)]2
- Special Emphasis Panel[ZRG1 CFS-J (80)]1
Most frequent institutions
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIVERSITY OF CALIFORNIA AT DAVIS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Develop a novel red blood cell-based microfluidic approach to assess and diagnose ME/CFS1R21AI175960-01A1 | WAN, JIANDI | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $224,955 | ZRG1 |
| 2023 | Correlating neutrophil function and plasma cytokine profiles with progression of ME/CFS and Long-Covid/PASC1R21NS130147-01 | ELLETT, FELIX | MASSACHUSETTS GENERAL HOSPITAL, MA | $252,000 | ZRG1 |
| 2021 | Proteomic identification of Myalgic encephalomyelitis/chronic fatigue syndrome1R21NS121852-01A1 | NATELSON, BENJAMINSCHUTZER, STEVEN E | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $374,856 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.